Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents

Wendy Laureijssen - van de Sande, AH Fahal, Irma Woudenberg, Alex Belkum

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)


Eumycetoma caused by Madurella mycetomatis is treated surgically and with high doses of ketoconazole. Therapeutic responses are poor, and recurrent infections are common. In search of therapeutic alternatives in the treatment of mycetoma, we determined the in vitro susceptibilities of M. mycetomatis isolates against caspofungin, anidulafungin, and micafungin. As a comparator fungus, Aspergillus fumigatus was used. Minimal effective concentrations (MECs) and MICs were assessed and compared to those of ketoconazole. M. mycetomatis isolates were not susceptible to the echinocandins.
Original languageUndefined/Unknown
Pages (from-to)2738-2740
Number of pages3
JournalAntimicrobial Agents & Chemotherapy
Issue number6
Publication statusPublished - 2010

Research programs

  • EMC MM-04-28-01

Cite this